Results 71 to 80 of about 26,722 (277)

Neonatal seizures: Advances in diagnosis and management

Epilepsia Open, EarlyView.
Abstract The International League Against Epilepsy (ILAE) created the ILAE Neonatal Task Force that classified neonatal seizures, defined neonatal epilepsy syndromes, and specified treatment guidelines. These frameworks, in addition to improved access to genetic testing and other recent advances, have revolutionized the diagnosis and management of ...
Elissa G. Yozawitz, Ronit M. Pressler, Eli M. Mizrahi   +2 more
wiley   +1 more source

Chemical analysis and concentrations of cannabidiol substances used for refractory epilepsy in Chilean patients. An underestimated worldwide risk

Epilepsia Open
Objective The purpose of this study is to analyze composition of HMS (homemade CBD), NLS (non‐licensed commercial products), and bioequivalent CBD (BES) collected from Chilean patients that voluntary accepted to analyze the “CBD‐substance.” Methods ...
Loreto Ríos‐Pohl, Macarena Franco, Daniel Navea, Viviana Venegas, Tomás Cerda   +4 more
doaj   +1 more source

Artificial intelligence in preclinical epilepsy research: Current state, potential, and challenges

Epilepsia Open, EarlyView.
Abstract Preclinical translational epilepsy research uses animal models to better understand the mechanisms underlying epilepsy and its comorbidities, as well as to analyze and develop potential treatments that may mitigate this neurological disorder and its associated conditions. Artificial intelligence (AI) has emerged as a transformative tool across
Jesús Servando Medel‐Matus, Cesar Santana‐Gomez, Ruby G. Escalante, Dominique Duncan, Pedro F. Viana, Giulia Sofia Cereda, Naoto Kuroda, Aristea S. Galanopoulou   +7 more
wiley   +1 more source

How do people with drug-resistant mesial temporal lobe epilepsy sleep? A clinical and video-EEG with EOG and submental EMG for sleep staging study

eNeurologicalSci, 2016
This study aimed to assess subjective and objective sleep parameters in a homogeneous group of drug-resistant mesial temporal lobe epilepsy (MTLE) patients through internationally validated clinical questionnaires, video-electroencephalographic (VEEG ...
Aline Vieira Scarlatelli-Lima, Lucia Sukys-Claudino, Nancy Watanabe, Ricardo Guarnieri, Roger Walz, Katia Lin   +5 more
doaj   +1 more source

The multiple hit model of infantile and epileptic spasms: The 2025 update

Epilepsia Open, EarlyView.
Abstract Objective Infantile and epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy manifesting with epileptic spasms and poor neurodevelopmental outcomes. There is an urgent need for the development of more effective and tolerated therapies.
Aristea S. Galanopoulou, Wenzhu B. Mowrey, Wei Liu, Anna Maria Katsarou, Qianyun Li, Oleksii Shandra, Solomon L. Moshé   +6 more
wiley   +1 more source

Frecuencia de Síntomas de Depresión en Pacientes Adolescentes con Epilepsia. Tratados en el Servicio de Consulta Externa de la Fundación Hospital de la Misericordia y Fundación Liga Central Contra La Epilepsia

Medicina, 2009
<p><span>*Este artículo está basado en la tesis de especialización de Carolina Ñungo bajo la dirección del segundo y tercer autor. Fragmentos de este artículo fueron presentados como poster en el XIV Congreso Nacional de Epilepsia en Medellín,
Carolina Ñungo, Adolfo Álvarez, Rafael Vásquez, Mauricio Espitia, Carlos Medina Malo, Álvaro Izquierdo   +5 more
doaj  

Vagus nerve stimulator implantation for epilepsy in a paediatric hospital: outcomes and effect on quality of life

Neurología (English Edition), 2015
Introduction: Epilepsy, which is present in 0.5–1% of the paediatric population, is one of the most frequent childhood neurological disorders. Approximately 20% to 30% of these cases will be drug-resistant.
A. Ulate-Campos, L. Cean-Cabrera, J. Petanas-Argemi, G. García-Fructuoso, J. Aparicio, A. López-Sala, A. Palacio-Navarro, M.J. Mas, J. Muchart, M. Rebollo, F.X. Sanmartí   +10 more
doaj   +1 more source

Self‐completed patient‐reported outcome measures in adults with epilepsy: A review

Epilepsia Open, EarlyView.
Abstract Epilepsy affects 65 million people worldwide, and is a World Health Organization priority disease as highlighted in their 2022–2031 Intersectoral Global Action Plan (IGAP) on Epilepsy and other Neurological Disorders. IGAP's objectives include improving epilepsy treatment and care.
Alison L. Conquest, Terence J. O'Brien, Patrick Kwan, Jacqueline A. French, Charles B. Malpas, Emma C. Foster   +5 more
wiley   +1 more source

Estudio de seguridad en la monitorización por vídeo-electroencefalograma prolongado

Neurología, 2014
Resumen: Introducción: En epilepsia farmacorresistente el incremento asociado de la morbimortalidad y el deterioro de calidad de vida hace necesario el ingreso en Unidades de Monitorización de Epilepsia (UME).
M. Ley, R. Vivanco, A. Massot, J. Jiménez, J. Roquer, R. Rocamora   +5 more
doaj   +1 more source

Late‐onset unexplained epilepsy as a risk factor for cognitive impairment and dementia: Protocol for a multi‐center prospective longitudinal observational study (ELUCID)

Epilepsia Open, EarlyView.
Abstract Objective Late‐onset unexplained epilepsy (LoUE), defined as epilepsy onset after age 55 without an obvious cause, is an important risk factor for dementia. Studies have shown that 10%–25% of individuals with LoUE develop dementia within 3–4 years following their first seizure.
Alice D. Lam, Emily L. Johnson, Rani A. Sarkis, Leah J. Blank, Tyler E. Gaston, Mouhsin M. Shafi, Rodrigo Zepeda, Kyle R. Pellerin, Nathalie Jette, Douglas N. Greve, Lori B. Chibnik, Rebecca E. Amariglio, Gad A. Marshall, M. Brandon Westover   +13 more
wiley   +1 more source